Skip to main content

Chloroprocaine Hydrochloride Injection

Last Updated: January 4, 2023
Status: Current

Products Affected - Description
    • Nesacaine solution for injection, Fresenius Kabi, 2% (20 mg/mL), 30 mL multiple dose vial, 25 count, NDC 63323-0476-37
    • Chloroprocaine hydrochloride solution for injection, Hikma, 2% (20 mg/mL), 20 mL preservative-free and EDTA-free single dose vial, 10 count, NDC 00143-9209-10
Reason for the Shortage
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
Available Products
    • Nesacaine solution for injection, Fresenius Kabi, 1% (10 mg/mL), 30 mL multiple dose vial, 25 count, NDC 63323-0475-37
    • Nesacaine-MPF solution for injection, Fresenius Kabi, 2% (20 mg/mL), 20 mL preservative-free and EDTA-free single dose vial, 25 count, NDC 63323-0477-27
    • Nesacaine-MPF solution for injection, Fresenius Kabi, 3% (30 mg/mL), 20 mL preservative-free and EDTA-free single dose vial, 25 count, NDC 63323-0478-27
    • Chloroprocaine hydrochloride solution for injection, Hikma, 3% (30 mg/mL), 20 mL preservative-free and EDTA-free single dose vial, 10 count, NDC 00143-9210-10

Estimated Resupply Dates

    • Fresenius Kabi has Nesacaine-MPF 20 mg/mL 20 mL vials on back order and the company estimates a release date of late-February to early-March 2023.
    • Hikma has chloroprocaine 20 mg/mL 20 mL preservative-free vials on back order and the company estimates a release date of late-February to early-March 2023.

Updated

Updated January 4, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 15, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.